{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:22:02Z","timestamp":1790374922449,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dumlup\u0131nar University Research Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.bioorg.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T23:13:40Z","timestamp":1468883620000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II"],"prefix":"10.1016","volume":"68","author":[{"given":"Samet","family":"Mert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"Al\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Mustafa","family":"\u0130\u015fg\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmi","family":"Kas\u0131mo\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2016.07.006_b0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/156802607780636735","article-title":"The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents","volume":"7","author":"Mincione","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0010","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1016\/j.bmcl.2004.07.085","article-title":"Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives","volume":"14","author":"Innocenti","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ddr.430100407","article-title":"Carbonic anhydrase: general perspective and advances in glaucoma research","volume":"10","author":"Maren","year":"1987","journal-title":"Drug Develop. Res."},{"key":"10.1016\/j.bioorg.2016.07.006_b0020","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/jm011131t","article-title":"Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design","volume":"45","author":"Abbate","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/21691401.2012.761226","article-title":"In vitro inhibition effect of some chalcones on erythrocyte carbonic anhydrase I and II","volume":"41","author":"Gencer","year":"2013","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2016.07.006_b0030","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with Triazole-linked O-glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0020-7519(01)00172-2","article-title":"Characterisation of carbonic anhydrase in Plasmodium falciparum","volume":"31","author":"Krungkrai","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.bioorg.2016.07.006_b0040","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic anhydrases as targets for medicinal chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0045","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0050","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.bmc.2014.12.054","article-title":"N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II","volume":"23","author":"Yildirim","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0055","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.bmc.2015.05.007","article-title":"Cloning, characterization and anion inhibition study of a \u03b2-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans","volume":"23","author":"Dedeoglu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0060","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.bmcl.2009.06.002","article-title":"The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian \u03b1-carbonic anhydrase isoforms","volume":"19","author":"Parkkila","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ardp.201300054","article-title":"Synthesis and biological evaluation of novel bromophenol derivatives as carbonic anhydrase inhibitors","volume":"346","author":"Akbaba","year":"2013","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2016.07.006_b0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/14756366.2011.570759","article-title":"Carbonic anhydrase inhibitors: purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides","volume":"26","author":"Ozensoy","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0075","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.bmc.2014.03.041","article-title":"Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff\u2019s bases incorporating sulfonamide, carboxylate and carboxymethyl moieties","volume":"22","author":"Nasr","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2016.07.006_b0085","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2016.07.006_b0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2016.07.006_b0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2016.07.006_b0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2016.07.006_b0105","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1021\/jm300878g","article-title":"Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit \u03b1- and \u03b2-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms","volume":"55","author":"Marini","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0110","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0960-894X(01)00303-1","article-title":"Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties","volume":"11","author":"Mincione","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/17425247.2010.497536","article-title":"Promising complexes of acetazolamide for topical ocular administration","volume":"7","author":"Granero","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioorg.2016.07.006_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/13543776.2012.649006","article-title":"Novel therapies for glaucoma: a patent review 2007\u20132011","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2016.07.006_b0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/jm060868l","article-title":"Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors","volume":"50","author":"Chimenti","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1081\/SCC-200054225","article-title":"Synthesis of 3,5-diphenyl-1H-pyrazoles","volume":"35","author":"Bhat","year":"2005","journal-title":"Synth. Comm."},{"key":"10.1016\/j.bioorg.2016.07.006_b0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bioorg.2014.12.003","article-title":"Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II","volume":"58","author":"El-Feky","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2011.12.011","article-title":"Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents","volume":"48","author":"Xu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ardp.201400084","article-title":"Efficient synthesis of novel 3-aryl-5-(4-chloro-2-morpholinothiazol-5-yl)-4,5-dihydro-1H-pyrazoles and their antifungal activity alone and in combination with commercial antifungal agents","volume":"347","author":"Ram\u00edrez","year":"2014","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2016.07.006_b0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2013.12.005","article-title":"Antinociceptive, anti-inflammatory and antipyretic effects of 1.5-diphenyl-1H-Pyrazole-3-carbohydrazide, a new heterocyclic pyrazole derivative","volume":"95","author":"Malvar","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2016.07.006_b0155","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1016\/j.bmc.2015.05.052","article-title":"5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII","volume":"23","author":"Cvijeti\u0107","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2012.03.056","article-title":"Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents","volume":"53","author":"Puthiyapurayil","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bmc.2012.11.012","article-title":"Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes","volume":"21","author":"Balseven","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/14756366.2010.491795","article-title":"Synthesis of 5-amino-1,3,4-thiadiazole-2-sulphonamide derivatives and their inhibition effects on human carbonic anhydrase isozymes","volume":"26","author":"Kasimogullari","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0175","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.bmc.2009.03.048","article-title":"Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes","volume":"17","author":"Kasimogullari","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/14756366.2011.651465","article-title":"Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme","volume":"28","author":"Sen","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2014.03.033","article-title":"Synthesis, structure\u2013activity relationships, and in vitro antibacterial and antifungal activity evaluations of novel pyrazole carboxylic and dicarboxylic acid derivatives","volume":"78","author":"Mert","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2015.05.020","article-title":"Novel pyrazole-3,4-dicarboxamides bearing biologically active sulfonamide moiety as potential carbonic anhydrase inhibitors","author":"Mert","year":"2015","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0195","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1039\/c0dt01527j","article-title":"Complexes of copper(II) with 3-(ortho-substituted phenylhydrazo)pentane-2,4-diones: syntheses, properties and catalytic activity for cyclohexane oxidation","volume":"40","author":"Kopylovich","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2016.07.006_b0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1515\/znb-2010-0610","article-title":"Unusual behaviour during the route of a Japp-Klingemann reaction","volume":"65","author":"Marten","year":"2010","journal-title":"Z. Naturforsch. B"},{"key":"10.1016\/j.bioorg.2016.07.006_b0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/zaac.200400496","article-title":"3-(Arylhydrazono)pentane-2,4-diones and their complexes with copper(II) and nickel(II)-synthesis and crystal structures","volume":"631","author":"Marten","year":"2005","journal-title":"Z. Anorg. Allg. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0210","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1080\/00032711003763665","article-title":"Ion pairs of 5,5-dimethyl-2-(2-hydroxy-3,5-disulfophenylhydrazo) cyclohexane-1,3-dione with cationic surface-active substances as analytical reagent for determination of copper(II)","volume":"43","author":"Mahmudov","year":"2010","journal-title":"Anal. Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0215","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/1099-0690(200208)2002:16<2764::AID-EJOC2764>3.0.CO;2-B","article-title":"Synthesis, 1H, 13C and 15N NMR study of azo coupling products from enaminones","volume":"2002","author":"\u0160im\u016fnek","year":"2002","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0220","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.tetlet.2005.01.131","article-title":"Solvent effects in a carbenoid NH insertion route to triarylamines via 2-diazo-1,3-cyclohexanedione","volume":"46","author":"Livant","year":"2005","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2016.07.006_b0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/anie.201107117","article-title":"Switching pathways: room-temperature neutral solvolysis and substitution of amides","volume":"51","author":"Hutchby","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2016.07.006_b0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bjo.2007.125187","article-title":"A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma","volume":"92","author":"Siesky","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bioorg.2016.07.006_b0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-1211(03)00078-0","article-title":"Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of Topiramate in epilepsy patients","volume":"54","author":"Kockelmann","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bioorg.2016.07.006_b0240","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/cbdd.12561","article-title":"Some anti-inflammatory agents inhibit esterase activities of human carbonic anhydrase isoforms I and II: an in vitro study","volume":"86","author":"Alim","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2016.07.006_b0245","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.ejmech.2010.07.041","article-title":"Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide","volume":"45","author":"Kasimogullari","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0250","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0968-0896(96)00272-6","article-title":"Synthesis and investigation of inhibition effects of new carbonic anhydrase inhibitors","volume":"5","author":"Arslan","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/phrs.2000.0674","article-title":"Effects of some medical drugs on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo","volume":"42","author":"Beydemir","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2016.07.006_b0260","first-page":"580","article-title":"Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II","volume":"59","author":"Ekinci","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2016.07.006_b0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9258(18)51011-5","article-title":"Electrometric and colorimetric determination of carbonic anhydrase","volume":"176","author":"Wilbur","year":"1948","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0270","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2016.07.006_b0280","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206816301316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206816301316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T07:54:52Z","timestamp":1656834892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206816301316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":56,"alternative-id":["S0045206816301316"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2016.07.006","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}